Inhibikase Therapeutics ( (IKT) ) has provided an announcement. Inhibikase Therapeutics, Inc. released a new presentation on ...

Blood cancer is not always fatal and advancements in treatment offer significant hope. Misconceptions exist, such as it being ...

Most employers have little idea what the pharmacy benefit managers they hire do with the money they exchange for the ...

A key gene that could enhance the treatment success rates of chronic myeloid leukemia (CML) has been discovered by ...

Dr Georgia Papacleovoulou, head of policy and advocacy at Leukaemia UK, said: "Unexplained bruising is one of the symptoms ...

Cogent Biosciences' uncertain competitive edge may compel investors to sit on the sidelines. Read more about the cautious ...

Most patients diagnosed with chronic-phase chronic myeloid leukemia (CP-CML) who achieved a deep molecular response on ...

By prioritizing health outcomes over financial gains, alternative pharmacies embody the potential for radical change in the pharmaceutical industry. They are a wake-up call for reform in the drug ...

Researchers are advising against the interruption of treatment with Gleevec among patients with advanced gastrointestinal ...

Fintel reports that on September 30, 2024, William Blair initiated coverage of Tenax Therapeutics (NasdaqCM:TENX) with a ...

The REXO5 protein has been shown to contribute to increased genomic instability through the formation of R-loop structures, where RNA attaches to damaged DNA. Insufficient levels of REXO5 lead to ...

Kura Oncology Inc (KURA) showcases promising developments in its oncology pipeline while navigating increased R&D expenses and financial pressures.